Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 3, 1996, Pages 897-902

  Paganini Hill, A ^a   Dworsky, R ^a   Krauss, R M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cholesterol; Estrogen; hormone replacement therapy; lipoproteins; progestin; triglycerides

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; ESTRATEST; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; NORETHISTERONE ACETATE; PIPERAZINE ESTRONE SULFATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029878969     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70322-8     Document Type: Article

References (25)

1. CA Derby AL Hume MM Barbour JB McPhillips TM Lasater RA Carleton Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities Am J Epidemiol 137 1993 1125 1135
2. E Barrett-Connor D Kritz-Silverstein Estrogen replacement therapy and cognitive function in older women JAMA 269 1993 2637 2641
3. MJ Stampfer GA Colditz Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence Prev Med 20 1991 47 63
4. TL Bush VT Miller Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins DR Mishell Menopause: physiology and pharmacology 1987 : Year Book Medical Chicago 187 208
5. Lipid Research Clinics Program. Manual of laboratory operations: lipid and lipoprotein analysis 1974 U.S. Department of Health, Education, and Welfare Washington, DC (Publication no NIH 75-628.)
6. AV Nichols RM Krauss TA Musliner Nondenaturing polyacrylamide gradient gel electrophoresis Methods Enzymol 128 1986 417 431
7. C-H Wu LE Lundy Radioimmunoassay of plasma estrogens Steroids 18 1971 91 111
8. P Wahl C Walden R Knopp Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol N Engl J Med 308 1983 862 867
9. WH Ettinger PW Wahl LH Kuller Lipoprotein lipids in older people: results from the Cardiovascular Health Study Circulation 86 1992 858 869
10. BW Walsh I Schiff B Rosner L Greenberg V Ravnikar FM Sacks Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins N Engl J Med 325 1991 1196 1204
11. BB Sherwin MM Gelfand A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids Obstet Gynecol 73 1989 759 766
12. UB Ottosson BG Johansson B von Schoultz Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone AM J OBSTET GYNECOL 151 1985 746 750
13. E Hirvonen A Lipasti M Mälkönen Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women Maturitas 9 1987 69 79
14. EWW Sonnendrecker ES Polakow AJS Benade E Simchowitz Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women AM J OBSTET GY-NECOL 160 1989 1128 1134
15. VT Miller RA Muesing JC LaRosa DB Stoy EA Phillips RJ Stillman Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I Obstet Gynecol 77 1991 235 240
16. The Writing Group for the Postmenopausal Estrogen/Progestin Interventions Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199 208
17. RM Krauss FT Lindgren J Wingerd DD Bradley S Ramcharan Effects of estrogens and progestins on high density lipoproteins Lipids 14 1979 113 118
18. L Fahraeus L Wallentin High density lipoprotein subfractions during oral and cutaneous administration of 17β-estradiol to menopausal women J Clin Endocrinol Metab 56 1983 797 801
19. JA Cauley RE LePorte LH Kuller Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function Atherosclerosis 49 1983 31 39
20. DM Hart E Farish CD Fletcher C Howie H Kitchener Ten years post-menopausal hormone replacement therapy - effect on lipoproteins Maturitas 5 1984 271 276
21. Z Blumenfeld M Aviram GJ Brook JM Brandes Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women Maturitas 5 1983 77 83
22. E Farish CD Fletcher DM Hart HTHTC Teo F Alazzawi C Howie The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women Acta Endocrinol (Copenh) 113 1986 123 127
23. PT Williams KM Vranizan MA Austin RM Krauss Associations of age, adiposity, alcohol intake, menstrual status and estrogen therapy with high-density lipoprotein subclasses Arterioscler Thromb 13 1993 1654 1661
24. MC Cheung BG Brown AC Wolf JJ Albers Altered particle size distribution of apolipoprotein A-I - containing lipoproteins in subjects with coronary artery disease J Lipid Res 32 1991 383 394
25. E Barrett-Connor DL Wingard MH Criqui Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited JAMA 261 1989 2095 2100